miraDry Secures CE Mark Certification for Expanded Solutions
miraDry, Inc., a leader in underarm sweat and odor treatment, recently achieved a significant milestone by obtaining CE marking under the European Union's Medical Device Regulation (EU MDR 2017/745). This groundbreaking accomplishment not only elevates miraDry's standing in the medical community but also introduces a broader scope for treating common concerns related to underarm sweat, odor, and hair.
Benefits of the Latest miraDry Innovations
With this certification, the miraDry system is set to enhance patient experience, as it comes with upgraded software capable of cutting treatment times by up to 30%. This advancement significantly improves the comfort of patients while optimizing clinic operations.
Accessibility of miraDry in Europe
Currently, miraDry is available through numerous providers across more than 14 European nations, having positively influenced the lives of over 500,000 patients worldwide. The treatment is known for its effectiveness, providing a unique solution to three prevalent underarm concerns—all within a single non-surgical procedure.
Market Demand for Effective Underarm Solutions
The growing interest in reliable underarm treatments is remarkably evident. The deodorant market in Europe is on track to climb to an impressive $16.15 billion in the coming years, with over 50 million consumers in the UK purchasing deodorants regularly. On the other hand, the sector for laser hair removal is projected to expand to approximately $1.22 billion, making underarms a primary area of treatment.
miraDry’s Commitment to Quality and Performance
Commenting on the recent achievements, Robert Catlin, the Chief Executive Officer of miraDry, emphasized the significance of securing the CE mark, affirming their dedication to delivering high-quality innovations. He expressed pride in providing a long-lasting solution to the increasing demand for sweat, odor, and hair reduction.
Clinical Performance and Regulatory Strength of miraDry
miraDry has established a reputation for excellence, continuously meeting rigorous international standards. Irene Mo, Vice President of Quality and Regulatory, stated that the robust technology behind miraDry offers long-lasting relief from underarm sweat, odor, and hair. The system is noted for its unique approach, effective across various skin and hair types, differing from traditional laser hair removal methods.
Proven Effectiveness of the miraDry Treatment
The effectiveness of miraDry is impressive; studies indicate that it can successfully reduce underarm odor in 97% of treated patients, with 89% no longer experiencing issues related to underarm odor. Moreover, the treatment is effective across different skin Fitzpatrick types, boasting a hair reduction rate of 70%.
About miraDry
miraDry offers an innovative, FDA-cleared treatment option specifically designed to tackle excessive underarm sweat, odor, and hair. As a non-invasive solution, it has delivered overwhelming satisfaction, with 90% of patients reporting positive outcomes. Currently, miraDry stands as the first and only treatment of its kind, with a global reach that has surpassed 500,000 treated patients to date. For more information, visit miraDry.com.
Frequently Asked Questions
What is miraDry?
miraDry is a non-surgical treatment designed to provide long-lasting support for excessive underarm sweat, odor, and hair reduction.
How does miraDry work?
The miraDry treatment uses microwave energy to target and reduce sweat glands and hair follicles in the underarm area.
What are the benefits of obtaining CE marking?
CE marking signifies compliance with European regulatory standards, ensuring the safety and efficacy of medical devices like miraDry in treating underarm concerns.
How widely available is miraDry?
miraDry is available at numerous medical providers across more than 14 countries in Europe, making it accessible to a wide range of patients.
What are the expected outcomes of miraDry treatment?
Patients can expect significant reductions in underarm sweat, odor, and hair, with most reporting a high level of satisfaction with their treatment results.
